Back Login for AI Analysis

    CBIO (STOCKS)

    Crescent Biopharma, Inc. Common Stock

    $12.700000
    +0.120000 (+0.95%)
    Prev close: $12.580000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Joshua T. Brumm
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $462.81M
    Employees
    44
    P/E (TTM)
    -1.64
    P/B (TTM)
    2.19
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —

    Analyst Recommendations
    6
    Strong Buy
    7
    Buy
    2
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    $-0.74 $-0.81 +0.0709 +8.74%
    Mar 2026 (Q1)
    $-0.70 $-0.97 +0.2655 +27.50%
    Dec 2025 (Q4)
    $-0.54 $-2.57 +2.0266 +78.96%
    Sep 2025 (Q3)
    $-1.27 $-2.02 +0.7516 +37.18%